India logs 39,742 new Covid-19 cases

New Delhi: India added 39,742 new cases of coronavirus infection taking the total tally of Covid-19 cases to 3,13,71,901, while the death toll rose to 4,20,551 with 535 fresh fatalities, according to the Union Health Ministry data updated on Sunday.

The active cases have declined to 4,08,212 and comprise 1.30 per cent of the total infections and the national Covid-19 recovery rate has been recorded at 97.36 per cent, the data updated at 8 am showed.

A decline of 765 cases has been recorded in the active Covid-19 caseload in a span of 24 hours.

India’s Covid-19 tally had crossed the 20-lakh mark on August 7, 30 lakh on August 23, 40 lakh on September 5 and 50 lakh on September 16.It went past 60 lakh on September 28, 70 lakh on October 11, crossed 80 lakh on October 29, 90 lakh on November 20 and surpassed the one-crore mark on December 19. India crossed the grim milestone of two crore on May 4 and three crore on June 23. As many as 17,18,756 tests were conducted on Saturday taking the total cumulative tests conducted so far for detection of Covid-19 in the country to 45,62,89,567.

The daily positivity rate was recorded at 2.31 per cent . It has been less than three per cent for 34 consecutive days, the ministry said, adding the weekly positivity rate was recorded at 2.24 per cent.

The number of people who have recuperated from the disease surged to 3,05,43,138, while the case fatality rate stands at 1.34 per cent, the data stated.

Cumulative vaccine doses administered so far has reached 43.31 crore under the nationwide vaccination drive.

The 535 new fatalities include 224 from Maharashtra and 98 from Kerala.

A total of 4,20551 deaths have been reported so far in the country including 1,31,429 from Maharashtra, 36,352 from Karnataka, 33,889 from Tamil Nadu, 25,041 from Delhi, 22,749 from Uttar Pradesh and 18,064 from West Bengal.

  • Related Posts

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’